On Monday, Lexeo Therapeutics Inc (NASDAQ: LXEO) opened higher 6.61% from the last session, before settling in for the closing price of $9.23. Price fluctuations for LXEO have ranged from $1.45 to $11.72 over the past 52 weeks.
During the last 5-year period, the sales drop of Healthcare Sector giant was -99.98%. Company’s average yearly earnings per share was noted 18.77% at the time writing. With a float of $42.55 million, this company’s outstanding shares have now reached $54.00 million.
Lexeo Therapeutics Inc (LXEO) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Lexeo Therapeutics Inc is 21.20%, while institutional ownership is 69.34%. The most recent insider transaction that took place on Oct 17 ’25, was worth 34,767. In this transaction Chief Development Officer of this company sold 3,888 shares at a rate of $8.94, taking the stock ownership to the 65,862 shares. Before that another transaction happened on Oct 17 ’25, when Company’s Chief Legal Officer sold 3,526 for $8.94, making the entire transaction worth $31,530. This insider now owns 68,930 shares in total.
Lexeo Therapeutics Inc (LXEO) Recent Fiscal highlights
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -0.89 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -0.67) by -0.22. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.42 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 18.77% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 15.54% during the next five years compared to -99.98% drop over the previous five years of trading.
Lexeo Therapeutics Inc (NASDAQ: LXEO) Trading Performance Indicators
Check out the current performance indicators for Lexeo Therapeutics Inc (LXEO). In the past quarter, the stock posted a quick ratio of 4.43.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.26, a number that is poised to hit -0.52 in the next quarter and is forecasted to reach -2.00 in one year’s time.
Technical Analysis of Lexeo Therapeutics Inc (LXEO)
Looking closely at Lexeo Therapeutics Inc (NASDAQ: LXEO), its last 5-days average volume was 1.09 million, which is a jump from its year-to-date volume of 0.73 million. As of the previous 9 days, the stock’s Stochastic %D was 66.85%.
During the past 100 days, Lexeo Therapeutics Inc’s (LXEO) raw stochastic average was set at 97.20%, which indicates a significant increase from 91.27% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.68 in the past 14 days, which was higher than the 0.42 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $6.47, while its 200-day Moving Average is $4.52. However, in the short run, Lexeo Therapeutics Inc’s stock first resistance to watch stands at $10.19. Second resistance stands at $10.54. The third major resistance level sits at $11.08. If the price goes on to break the first support level at $9.30, it is likely to go to the next support level at $8.76. Now, if the price goes above the second support level, the third support stands at $8.41.
Lexeo Therapeutics Inc (NASDAQ: LXEO) Key Stats
There are currently 54,001K shares outstanding in the company with a market cap of 531.37 million. Presently, the company’s annual sales total 0 K according to its annual income of -98,330 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -26,100 K.
